Abstract Osteoporosis and associated fractures are major public health concerns, and as such require appropriate large animal models to further our understanding of this disease. Although sheep appear to be an ideal model with which to study bone loss caused by estrogen depletion, limited data are available concerning the long-term effect of ovariectomy on bone in sheep. The goal of the present study was to observe the ovariectomy-induced changes in bone mass, structure, and metabolism in sheep over a period of 18 months. Six ewes were ovariectomized (OVX) and compared to an age-matched control group by analyzing bone mineral density, trabecular structure, biochemical markers of bone formation and resorption, and plasma estrogen levels. Bone loss (13%, P < 0.01) occurred during the first 4 months after surgery, then stabilized and returned to pre-OVX levels for the remainder of the study. Trabecular architecture was also altered and tended toward osteopenia with recovery to baseline values. Markers of bone formation and resorption were elevated up to 6 months postovariectomy, after which time levels returned to baseline values. Although estradiol measurements demonstrated a clear decline following surgical ovariectomy, levels returned to normal after 6 months. Therefore, the detrimental effect of ovariectomy on sheep bone metabolism seems to be reversible, with normal bone parameters being reestablished within 6 months after surgery. These data seem to indicate that the sheep is not an appropriate model for human postmenopausal osteoporosis.
Introduction
Because of the dramatic increase in the elderly population and the rise in the incidence of fractures, osteoporosis has become a major public health concern [1] [2] [3] . Because new treatment strategies and better fixation methods in such fragile bones cannot be developed in vitro, there is a great need for suitable animal models that closely simulate osteoporosis in humans [4] .
Various experimental models of human osteoporosis have been described in several different species [4] . The ovariectomized rat is probably the most widely studied rodent osteoporotic model. This model mimics postmenopausal cancellous bone loss over a relatively short time period [5, 6] . However, extended studies over 12 months have demonstrated increased bone mineral content, bone area, and body weight, which is not comparable to the human situation [7, 8] . Furthermore, the lack of the Haversian system in cortical bone, the absence of impaired osteoblast function during late stages of estrogen deficiency, and the absence of multicellular unit-based remodeling in young rats also limits this model [9] . An additional requirement of experimental osteoporosis models is the ability to assess the performance of surgical implants. Such procedures are clearly impractical in the experimental rat model due to limitations in size. The "FDA Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Treatment of Prevention of Postmenopausal Osteoporosis" recommend agent evaluation in two different species including ovariectomized rats and one nonrodent large animal model [10] . Although these guidelines primarily pertain to pharmaceutical drugs, preclinical evaluation is also required for new surgical treatment options. Therefore, there is an obvious need for large as well as small animal models of osteoporosis.
Large animal osteoporosis models include nonhuman primates, dogs, and sheep. Monkeys such as baboons and macaques have an advantage over other osteoporosis models because of their close physiological resemblance to humans, including gastrointestinal tract, endocrine system, and bone metabolism [11] [12] [13] . Female monkeys have hormonal patterns and a monthly cycle very similar to those of humans. Aged macaques and baboons experience a similar decline in ovarian function and irregular menstrual cycles as in peri-and postmenopausal women. However, for ethical reasons and reasons of handling costs, the experimental use of these species is rather limited.
Dogs possess cortical bone with a Haversian system and manifest internal cortical and cancellous bone remodeling processes similar to those in humans. Studies have evaluated the effects of ovariectomy on histomorphometric variables in cancellous and cortical bone in several breeds of dog [14] [15] [16] [17] [18] [19] . Although significant changes in cancellous bone volume were observed in these studies, the data are conflicting and suggest that canine experimental osteoporosis may not be the most suitable animal model for studying bone loss following ovariectomy. More importantly, fracture rates in aged, sedentary dogs without ovaries and uteri are not comparable to those of postmenopausal women [20] . Finally, emotional attachment to dogs, along with the stringent legal housing requirements, contribute to the difficulties in using this experimental model of osteoporosis.
Sheep have been extensively studied as an experimental model of bone disease [4] . Bone loss in sheep is associated with estrogen deficiency, and their hormone profiles are similar to those of women [21] [22] [23] [24] . Their size permits the implantation of prosthetics, and isolation of large quantities of fluid samples as well as iliac crest biopsies [25] . Although reports have not described consistent decreases in bone mineral density or bone mass at different anatomical locations, significant changes in these parameters have been demonstrated in the distal radius and spine [26] . Biochemical markers of bone formation such as bone-specific alkaline phosphatase were reported to increase in sheep after ovariectomy [24] , indicating an increase in bone turnover similar to the human postmenopausal situation. However, only a 10% reduction in sheep bone mass has been attained through old age or estradiol privation following ovariectomy, whereas in osteoporotic humans this value is at least fourfold higher [27] . Reports describing the long-term effects of ovariectomy in sheep are limited, and studies have predominantly focused on animals post mortem or in large time intervals [22] . Furthermore, the reported effects of ovariectomy on estrogen levels in ewes are highly controversial [28, 29] . In the present study, we examined the longterm effects of ovariectomy on bone density, structure, and metabolism in sheep. Multiple parameters of bone turnover including mineral density [using peripheral quantitative computed tomography (pQCT)], 3-D trabecular architecture, and biochemical markers are investigated and their association with estradiol hormone levels determined.
Materials and methods

Study design
The European and Swiss laws on animal experimentation were strictly observed during the entire study, and the animal research protocol was approved by a competent ethical committee. Fourteen female white alpine sheep with a mean age of 3.1 ± 0.7 years at the beginning of the study were included in this study. They were divided into two groups based on bone mineral density (BMD) and body weight so that there would be no statistical differences between the means. Six sheep were ovariectomized (OVX) while the others (n = 8) were used as a control group (control).
The sheep were held in group boxes under standardized conditions and natural light, and their body weight was measured weekly. During the entire observation period, the animals were fed twice daily with silage (1.5 kg/animal · day; 10.3 g/kg calcium, 4.1 g/kg phosphorus), hay (0.25 kg/ animal · day; 6.3 g/kg calcium, 2.8 g/kg phosphorus), and straw as well as water ad libidum. Urine and venous blood samples were collected on days 28, 14, and 1 before surgery and every fourth week after surgery for quantification of bone markers and hormones. The BMD was measured at the distal radius by pQCT 2 weeks before surgery and at 3-month intervals after surgery. For micro-CT measurements, bicortical iliac crest biopsies were taken at the time of the ovariectomy and at 3, 6, and 9 months after surgery. The study ended 18 months after surgery.
Surgical procedures
In April 2003, six ewes (treatment group) were subjected in supine position to midventral laparatomy under general anesthesia with isofluran (Halocarbon Laboratories, River Edge, NJ, USA) and intravenous Temgesic (buprenorphine HCl 0.3 mg/ml; Reckitt & Colman Pharmaceutics, Hull, UK). Bilateral ovariectomy was performed, with care being taken to ligate doubly the ovarian ligament, artery, and vein. Postoperative pain medication was given as necessary.
Bicortical transiliacal biopsies were taken under general anesthesia in all 14 animals bedded in prone position. To cut these out, a trephine drill (TL 05 trephine 2.0; external diameter 7.3 mm, internal diameter 6.4 mm) under constant irrigation was used. The length of the biopsies was given by anatomical conditions, as the transfixion was made 1 cm below the iliac crest, alternating medial and lateral from the spina iliaca, either on the right or on the left pelvic bone.
BMD measurement
Bone mineral density (BMD in grams per cubic centimeter) was measured by pQCT using a Densiscan 1000 (SCANCO Medical, Bassersdorf, Switzerland). The distal radius of both sides was examined. To avoid artefacts caused by movement, the measurements were performed under general anesthesia. After fixation of the limb in the CT scanner, a projectional scout view was accomplished to determine the axial position. The joint surface was defined as the starting point using a reference line. A highly filtered low-energy X-ray source was used to enhance the bone contrast. The effective energy of the X-ray beam was always set to 40 keV and 0.5 mil modus. The slice thickness was 1 mm, and a matrix of 512 × 512 pixels was used, resulting in a spatial resolution of 290 × 290 µm. Ten consecutive slices were obtained, and a contour surrounding the radius on each cross section was detected. The µ50-CT value was calculated using the interior 50% of a section to ensure that only cancellous bone was measured.
Structural parameters in micro-CT After harvesting transiliacal biopsies and immediate fixation in 70% ethanol, micro-CT scans using MicroCT 40 (SCANCO Medical) were performed. This system uses a fan-beam in a multislice mode. An X-ray tube with microfocus is used as source and a charge-coupled device (CCD) array as detector. The spatial resolution was 22 µm in all directions. The volume of interest included a cube with a side length of 4 mm and was displayed in 14 × 14 × 14 cubic micron voxels. Bone volume/total volume (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and the degree of anisotropy (DA) were measured.
Bone markers
Venous blood samples were allowed to clot for 30 min at room temperature. The serum then was collected by centrifugation (30 min at 4000 rpm, room temperature). Serum samples were stored at −20°C until assay.
Bone-specific alkaline phosphatase (bALP)
Serum bALP levels were determined by enzyme-linked immunosorbent assay (ELISA), using the Metra BAP EIA kit (TECOmedical; Suhr CH). Principle of the procedure: Metra BAP is an immunoassay in a microtiter strip format utilizing a monoclonal anti-BAP antibody coated on the strip to capture BAP in the sample. The enzyme activity of the captured BAP is detected with a pNPP substrate. Control samples were within the given range [14.9 and 15.4 U/l for low control (range, 9.8-21.1 U/l) and 64.3 and 86.6 U/l for high control (range, 62.0-97.2 U/l)].
Deoxypyridinoline (DPD) cross-links
As no reliable method to measure DPD in sheep urine was found except for the HPLC method, which is very time consuming and laborious for such a large amount of samples, the METRA DPD ELISA was used. HPLC and DPD ELISA have been compared in a parallel measurement with a few samples showing a significant relationship. The METRA DPD ELISA is a competitive enzyme immunoassay (TECOmedical). DPD in the sample competes with conjugated DPD-alkaline phosphatase for the antibody, and the reaction is detected with a pNPP substrate. Control samples were measured as 16.8 and 15.1 nmol/l for low control (range, 13.1-21.4 nmol/l) and 86.2 and 92.2 nmol/l for high control (range, 71.0-115.9 nmol/l). The analysis using the ELISA method was verified by HPLC.
The DPD results were corrected for urinary concentration by creatinine, which was quantified by the METRA Creatinine assay from TECOmedical based on a quantitative, colorimetric assay (modified Jaffé method).
Pyridinoline (PYD)
For a quantitative measure of the excretion of pyridinoline (PYD) cross-links in serum, the METRA Serum PYD EIA kit (TECOmedical), a competitive enzyme immunoassay in a microtiter plate, was used. PYD in the samples or standards competes with PYD immobilized on the plate for polyclonal rabbit anti-PYD antibody. Bound antibody is detected by goat antirabbit antibody conjugated to ALP, and the reaction is detected with the pNPP substrate. Control samples were measured as 2.0 and 2.3 nmol/l for low control (range, 1.6-2.6 nmol/l) and 6.5 and 8.1 nmol/l for high control (range, 6.3-10.4 nmol/l).
Hormone estradiol (E 2 )
Serum estradiol levels were determined with the 17β-Estradiol ELISA from IBL Hamburg (Germany). Principle of the procedure: an unknown amount of estradiol present in the sample and a fixed amount of estradiol conjugated with horse-radish peroxidase compete for the binding sites of a polyclonal estradiol antiserum coated onto the wells. The manufacturer's protocol was followed as described, and samples were assayed in duplicates. The intra-and interassay coefficients of variation and the limits of detection were 4.9%-5.9%, 6.2%-10.1%, and 3 pg/ml, respectively. All values below the detectable limit were recorded as 0 pg/ml. The controls were within the given ranges (low control, 115 and 101 pg/ml vs. 50-130 pg/ml; high control, 384 and 218 pg/m vs. 168-432 pg/ml).
In addition to the method mentioned above, the serum estradiol levels were determined at an external, independent laboratory (Diavet, Bäch CH) with extensive experience in biochemical veterinary diagnostics. 17β-Estradiol was measured using an electrochemiluminescent-sandwich ELISA.
Statistical analysis
Statistical analysis was performed using SPSS software package (SPSS, Chicago, IL, USA). Results are presented as mean ± standard deviation. For comparison between the groups, analysis of variance (ANOVA) was used for bone markers, and nonparametric testing (Mann-Whitney test) was used for others. The level of significance was set at 0.05.
Results
All animals tolerated the surgical procedures well without any side effects. One ovariectomized sheep died at 16 months of observation of an esophageal infection that was not related to the treatment methods of this study. During the entire observation period, the mean body weight was 67.6 ± 4.5 kg for control and 67.5 ± 5.3 kg for OVX. The body weight fluctuated over time but the individual changes were below 10% in all sheep. No differences at any time point were found between the groups.
Bone mineral density
The cancellous bone mineral density at distal radius in control sheep remained constant with time at ∼0.71 g/cm 3 to 17 months. The course of cancellous BMD in the control group showed small changes with a slight decrease at the beginning of the study followed by minimal increase at 15 months. All changes were not significant compared to baseline. OVX sheep exhibited an rapid, initial phase of cancellous bone loss of −12.7% (P = 0.008) between 0 and 4 months postovariectomy. Then, a period of relative stabilization of cancellous bone volume at this osteopenic level occurred between 4 and 12 months, followed by a phase of minimal increases in bone mass until 17 months postssurgery (Fig. 1) .
Static bone morphometry and trabecular architecture by micro-CT Changes of the structural parameter in cancellous bone of the iliac crest are shown in Fig. 2 . Following ovariectomy, the parameters bone volume to total volume (BV/TV) (3 months, P = 0.007; 6 months, P = 0.010) and trabecular thickness (3 months, P = 0.010) decreased up to 6 months Bone markers Figure 3 depicts the serum bALP patterns over the first phase (6 months) of observation. The control group shows seasonal variations that must be considered, whereas in the OVX group there is a 50% elevation of bALP at 2 months after ovariectomy (P = 0.015). In this group, bALP decreased until a fall toward baseline values, but was still elevated at 6 months compared to the control group (P = 0.006). No differences were found at any later time point. Increased levels of serum pyridinoline were found at 2 months after ovariectomy only (P = 0.005), and no differences between the groups were determined at any later time point up to 18 months. The urine DPD values did not show significant differences between the controls and the ovariectomised sheep. Estradiol 17β-Estradiol decreased 3 months after ovariectomy (P = 0.021) in the treated group to values below the detection limit (3 pg/ml) and then increased massively in both groups. The developing of the control values showed a period of anestrus in May and June, followed by the breeding season in fall and winter with higher serum estradiol levels (mean, 20.8 pg/ml) (Fig. 4A) . With the exception of significant decrease of estrogen levels following ovariectomy, no differences were found between the two groups (Fig. 4B) . The data were validated using a different method at an independent laboratory.
Discussion
This study investigated the long-term effect of ovariectomy on ewes, demonstrating an early bone loss (−13%) followed To investigate postmenopausal bone loss and its consequences, there is a great need to develop an osteoporotic animal model for the testing of orthopedic implants as well as for pharmacological research on prevention and treatment. Sheep show several advantages as a model for osteoporosis: easy handling and keeping, availability in large numbers so that large-scale studies are possible, implant dimensions comparable to human implants, similar metabolic rate and bone remodeling process as humans [4, 25] , and osteopenic response to menopause-simulating manipulations [24, 28, 29] .
The present study evaluated the effect of ovariectomy on bone metabolism in sheep by determining bone mass, bone microarchitecture, and biochemical markers of bone formation and resorption as well as estradiol. Dietary effects were excluded by standardized feeding, and a bias due to physical activity was constrained by single group husbandry. The surgery was performed in spring when the lowest bone mass is usually observed to minimize seasonal influences on bone loss following ovariectomy. As ovariectomy is a standard procedure in our institution [30] , the authors omitted a sham group to avoid the use of more animals in the study, as requested by the ethical committee, although all sheep had bilateral transiliacal biopsies. Therefore, a limitation of this study is the lack of a true sham-operated control group because the effect of ovariectomy cannot be distinguished from any influences of wound healing. Prior studies have demonstrated an increased bone turnover following ovariectomy in sheep leading to a loss of bone mass of approximately 10%. Geusens et al. observed a nonsignificant bone loss of −3% to −9% at the femur [31] , Lill et al. measured a decrease of 5.5% of BMD at the distal radius in ovariectomized sheep with a calcium-wasting diet [30] , and several publications by Turner et al. report a decline of BMD from 3% to 8% [20, 24, 25] . However, it has not been determined whether these small ruminants experience a short-term effect of ovariectomy or if they develop osteoporosis over a longer period of time as it is the case in humans.
In the present study, most of the bone loss (−13%) occurred during the first 4 months postovariectomy. This initial, rapid phase was followed by a period between 7 and 9 months during which cancellous bone mass appeared to stabilize at the mentioned osteopenic level. Afterward, the bone mass seemed to increase toward baseline values. The changes of bone mass in control group are the result of seasonal changes [20] . During the period between 7 and 14 months, both bone loss and bone turnover subsided. The rapid, initial phase of bone loss is coincident with the maximal increase in bone turnover, which confirms previously reported studies [32] . These data clearly suggest short-term effects on bone mass in ovariectomized ewes.
Several other studies have been determining BMD using dual-energy X-ray absorptiometry (DXA), either on spine, femur, calcaneus, or distal radius, with different results [23, 24] . BMD measurements by DXA (a two-dimensional technique) are affected by skeletal size, and changes in density may be obscured by the mass of wool, soiling of the skin, and subcutaneous fat layer [33] . Measurement of volumetric BMD by pQCT, however, is advantageous as it is independent of skeletal size; it allows for selective measurement of cortical and trabecular density and bone area [34] .
As many recent studies have shown that BMD alone is not sufficient to determine the strength of cancellous bone, we also looked at static bone morphometry and trabecular architecture using microcomputed tomography [35, 36] . Those parameters are important factors in determining bone strength and the risk of fractures. Microcomputed tomography (micro-CT) enables the complete threedimensional digitization of small specimens at resolutions between 10 and 75 µm. It has the ability to provide quantifiable measures of bone architecture and morphology in three dimensions, giving the exact structure of a bone biopsy. The decrease in BV/TV accompanies a decrease of trabecular thickness. Although the loss of bone mass in postmenopausal women is driven by decrease of trabecular number [37] , the results are similar to previous reports [26] and indicate increased bone resorption and thinning of the trabecular structures.
Bone-specific alkaline phosphatase (bALP) has been analyzed to measure bone formation. While the control group shows seasonal fluctuations, an elevation of serum bALP levels until 6 months postovariectomy can be observed indicating an increased bone turnover. No differences between the groups were observed at any time point later than 6 months. Turner et al. [24] as well as Chavassieux et al. [21] also describe a high bone turnover after ovariectomy. Similar to our results, a trend toward decreasing levels until the end of the study (6 months) can be found. However in both publications, the seasonal timepoint of the ovariectomy is unknown.
To show bone resorption, the pyridinoline cross-links deoxypyridinoline (DPD) and pyridinoline (PYD) have been quantified. Those cross-links are formed during the process of collagen maturation between the chains, and as bone collagen undergoes a higher turnover rate than other tissue sources of collagen, these are specific markers for bone resorption. We found increased levels of bone resorption marker at 2 months after ovariectomy only. Chavassieux et al. [21] observed the highest increase of type 1 collagen C-telopeptide at 3 months after ovariectomy.
By removing the ovaries, the major source of estrogens is eliminated to simulate as much as possible the situation after menopause in women. Very few authors of studies about ovariectomy have tested the estradiol levels of the animals after operation. Johnson et al. writes that ovariectomy does not totally eliminate 17-β-estradiol synthesis in sheep (values between 4 and 6 pg/ml) [28] , whereas Karsch et al. postulates that serum estradiol concentrations in intact anestrous ewes average 1 pg/ml and that estradiol levels in ovariectomized animals are well below the limit of detection of any biochemical assay [29] . As the opinions over this topic are divergent and not much literature can be found, estradiol has been quantified in all animals of this study. The results show a significant drop in systemic estrogen levels as a result of ovariectomy followed by increased values without differences in the control group. These data highly suggest the presence of non-ovarian estradiol generation in ovariectomized animals.
Although the ovaries are the principal source of systemic estrogen in the premenopausal nonpregnant woman, estrogen biosynthesis beyond menopause is mainly peripheral, through conversion of androstendione or C19 steroids from the adrenal cortex. Other major sites of estrogen production such as adipose tissue and skin, muscle, and others have the capacity to convert C19 steroids to C18 steroids, but as they lack the ability to synthesize C19 precursors, they are dependent on circulating precursor C19 steroids for estrogen biosynthesis [38, 39] . Sheep somehow seem to compensate particularly well for estrogen deficiency, which probably is one of the reasons why ovariectomy only causes slight effects on ovine bone [30] . Further investigations are needed to determine the source of extragonadal extrogen. The ovariectomized sheep still might become a large animal model of postmenopausal osteoporosis, but reduction of nonovarian estrogen production using aromatase inhibitors is indicated. Contrary to glucocorticoid excess, this inhibitor would simulate perfectly the mechanism of bone loss in postmenopausal women. In the study by Chavassieux et al., the administration of lentaron, a specific inhibitor of peripheral aromatase, during 6 months tended to amplify slightly the effects of ovariectomy on bone markers [21] . Because of seasonal variations and calcium intake, experiments in sheep should include all four seasons to minimize the seasonal fluctuations and also a calcium-wasting diet [25] .
In summary, this study used a large variety of assessment methods to evaluate the long-term effect of ovariectomy in sheep to establish a large animal model of osteoporosis. Ovariectomy induced bone loss, leading to decreased bone mineral density (−13%) and deterioration of microarchitecture. However, the destructive effect was limited to a few months, and a rebound was observed in all treated animals. Our results suggest a short-term bone loss after ovariectomy in sheep is probably caused by extragonadal estrogen production. These data seem to indicate that ovariectomy in sheep does not simulate postmenopausal osteoporosis and that sheep are therefore not suitable for long-term investigations.
